Published in TB and Outbreaks Week, April 9th, 2002
Rifabutin failed for five of the patients because they built up resistance to the drug, the CDC said. All five patients had taken frequent doses of similar drugs earlier in their TB treatment.
The CDC halted the drug trial March 6, 2002, but said rifabutin remains a highly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week